Biosynthesis of tetrahydrobiopterin: conversion of dihydroneopterin triphosphate to tetrahydropterin intermediates

Biochemical and Biophysical Research Communications
S Milstien, S Kaufman


It is known that the first step in the de novo synthesis of tetrahydrobiopterin from GTP is the conversion of GTP to dihydroneopterin triphosphate. Recent evidence supports the conclusion that beyond this first step, the pterin intermediates in the pathway are all at the tetrahydro level of reduction. We have now shown that partially purified fractions from rat liver, rat brain and bovine adrenal medulla catalyze the conversion of dihydroneopterin triphosphate to tetrahydrobiopterin, as well as to the putative intermediates in the pathway, 6-pyruvoyl-tetrahydropterin and 6-lactoyl-tetrahydropterin. Results of both enzymatic and chemical studies support the assigned structures for the latter two tetrahydropterins. We have also purified extensively from brain an enzyme, distinct from sepiapterin reductase, that catalyzes the TPNH-dependent reduction of 6-pyruvoyl-tetrahydropterin to 6-lactoyl-tetrahydropterin. The role of this reductase in tetrahydrobiopterin synthesis has not yet been established.


Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·C A NicholD S Duch

❮ Previous
Next ❯


Sep 1, 1990·Zeitschrift für Ernährungswissenschaft·M KollerM Merkenschlager
Jun 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·J Ferre, E W Naylor
Dec 13, 1985·Biochimica Et Biophysica Acta·T Sueoka, S Katoh
Jan 1, 1996·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·P Ruiz-VázquezJ Ferré
Oct 1, 1994·Insect Biochemistry and Molecular Biology·J P Primus, G M Brown
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K TanakaS Milstien
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B A CitronS Kaufman
Feb 15, 1989·European Journal of Biochemistry·E C Webb
Mar 1, 1989·European Journal of Biochemistry·T Hasler, H C Curtius
Sep 3, 2003·Pigment Cell Research·Sumiko NegishiSetsuko Katoh
Mar 29, 1991·Biochemical and Biophysical Research Communications·Y S ParkN Blau
Jun 1, 1987·Archives of Biochemistry and Biophysics·G K Smith
Jan 1, 1989·Medicinal Research Reviews·T NagatsuT Sugimoto
Feb 25, 2009·Prikladnaia biokhimiia i mikrobiologiia·T A LiudnikovaM S Kritskiĭ
Nov 15, 1989·Biochemical and Biophysical Research Communications·P SteinerstauchH C Curtius

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.